Le Lézard
Classified in: Health, Business
Subject: ERP

Welltower Raises 2023 Guidance and Issues Business Update


TOLEDO, Ohio, June 6, 2023 /PRNewswire/ -- Welltower® Inc. (NYSE: WELL) today announced that it has revised its 2023 outlook. The Company now expects to achieve normalized funds from operations in a range of $3.43 - $3.56 per diluted share as compared to previous guidance of $3.39 - $3.54 per diluted share.  Additional details regarding the Company's updated guidance and other recent developments are contained in the following Business Update presentation:

https://welltower.com/june52023-business-update

About Welltower

Welltower® Inc. (NYSE: WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers, and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada, and the United Kingdom, consisting of seniors housing, post-acute communities and outpatient medical properties. More information is available at www.welltower.com.

SOURCE Welltower Inc.


These press releases may also interest you

at 05:30
Accelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers
Spanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC)...

at 05:00
New Affordable Assisted Living Community Opened in Valparaiso, IN
A VIP Party and Ribbon-Cutting Ceremony was held for Green Oaks of Valparaiso, a new affordable assisted lifestyle community for older adults is now...

at 04:00
The Galien Foundation Announces 2024 Prix Galien UK Award Candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product" and "Best Public Sector Innovation"
The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2024 Prix Galien UK Award candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical...

at 04:00
Novo Nordisk Foundation, Rigshospitalet and CNIC press release: One in three people die due to atherosclerosis: A new initiative aims to find new ways to prevent it
Globally, cardiovascular diseases due to atherosclerosis ? the build-up of plaque in arteries ? are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and...

at 03:33
Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has received confirmation of an extension of its contract with The Norwegian Hospital Procurement Trust (Sykehusinnkjøp HF)...

at 03:00
ALLCLEAR TRAVEL RESEARCH: ONE IN FOUR PEOPLE WITH MEDICAL CONDITIONS RISK INVALIDATING THEIR TRAVEL INSURANCE WHEN TRAVELLING ABROAD
One in four people with pre-existing medical conditions (25%) say they will not declare all of their medical conditions when buying travel insurance, with 40% of these only declaring what they are currently being treated for. Of those that would not...

More news about Health...


News published on and distributed by: